BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12101690)

  • 1. [Carboplatin].
    Watanabe H
    Nihon Rinsho; 2002 May; 60 Suppl 5():366-9. PubMed ID: 12101690
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gemcitabine].
    Takeda K
    Nihon Rinsho; 2002 May; 60 Suppl 5():359-65. PubMed ID: 12101689
    [No Abstract]   [Full Text] [Related]  

  • 3. [Docetaxel].
    Takigawa N
    Nihon Rinsho; 2002 May; 60 Suppl 5():349-52. PubMed ID: 12101686
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapy for elderly patients with lung cancer].
    Okamoto H; Watanabe K
    Nihon Rinsho; 2002 May; 60 Suppl 5():591-5. PubMed ID: 12101743
    [No Abstract]   [Full Text] [Related]  

  • 5. Lung cancer: therapeutic options for stage IV and recurrent NSCLC.
    Calvo AR; Belani CP
    Cancer Treat Res; 2001; 105():189-227. PubMed ID: 11224988
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemoradiation in locally advanced non-small cell lung cancer.
    Bonomi P; Shirazi W
    Cancer Treat Res; 2001; 105():171-88. PubMed ID: 11224987
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combinations of platinum salts and gemcitabine in the treatment of non-small-cell lung cancer].
    Souquet PJ; Gerinière L
    Bull Cancer; 2002 Aug; 89 Spec No():S80-4. PubMed ID: 12449035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Second-line and beyond: Docetaxel in the treatment of non-small-cell lung cancer].
    Rinaldi M
    Tumori; 2001; 87(6):A6-9. PubMed ID: 11995708
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phase III clinical trials concerning non-small-cell lung carcinoma (NSCLC) presented at the ASCO 2001].
    Morere JF
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S37-41. PubMed ID: 11924242
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel.
    Edelman MJ; Clark JI; Chansky K; Albain K; Bhoopalam N; Weiss GR; Giguere JK; Kelly K; Crowley J; Gandara DR
    Clin Cancer Res; 2004 Aug; 10(15):5022-6. PubMed ID: 15297403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in treatment of inoperable NSCLC: gemcitabine doublets--a promising alternative.
    Cappuzzo F; Rocha Lima CM; Sherman CA; Green MR
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 4):7-14. PubMed ID: 10960939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel (Taxotere) in combination chemotherapy and in association with thoracic radiotherapy for the treatment of non-small-cell lung cancer. Thoracic Oncology Program.
    Ornstein DL; Nervi AM; Rigas JR
    Ann Oncol; 1999; 10 Suppl 5():S35-40. PubMed ID: 10582137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highlights from the 10th World Conference on Lung Cancer. Vancouver, British Columbia, Canada, August 10-14, 2003.
    Clin Lung Cancer; 2003 Nov; 5(3):142-7. PubMed ID: 14667269
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy in lung cancer].
    Seto T
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1202-6. PubMed ID: 17847581
    [No Abstract]   [Full Text] [Related]  

  • 15. Rationale for non-platinum chemotherapy in advanced NSCLC.
    Murren JR
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):29-34. PubMed ID: 11497229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer.
    Zhu J; Sharma DB; Chen AB; Johnson BE; Weeks JC; Schrag D
    Cancer; 2013 Jun; 119(11):2048-60. PubMed ID: 23564469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New neoadjuvant approaches using gemcitabine in non-small-cell lung cancer].
    Depierre A; Westeel V; Jacoulet P
    Bull Cancer; 2002 Aug; 89 Spec No():S76-9. PubMed ID: 12449034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy in metastatic non-small-cell lung cancer.
    Sandler A
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):15-27. PubMed ID: 10981287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer.
    Tumolo S; Toffoli G; Saracchini S; Lo Re G; Bruschi G; Boccieri MG
    Lung Cancer; 2001 Dec; 34 Suppl 4():S37-46. PubMed ID: 11742701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.